Solifenacin hydrochloride,
Solifenacin (hydrochloride),
Vesicare,
180468-39-7,
NCGC00168778-01,
AC1L4BM0,
DSSTox_CID_26783,
DSSTox_RID_81901,
DSSTox_GSID_46783,
C23H26N2O2.ClH,
CHEMBL2361425,
DTXSID4046783,
CTK8F0005,
YAUBKMSXTZQZEB-VROPFNGYSA-N,
HY-I0230,
Tox21_112639,
4058AH,
AKOS030241618,
API0000838,
CS-2661,
YM 67905,
RT-015753,
CAS-180468-39-7,
FT-0674629,
(1S)-(3R)-1-Azabicyclo[2.2.2]oct-3-yl 3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate Butanedioic Acid,
(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid (3R)-1-Azabicyclo-[2.2.2]oct-3-yl Ester Succinate Salt,
[(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate hydrochloride,
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester, hydrochloride (1:1), (1S)-,
Vesikur,
Solifenacin HCl,
Solifenacin succinate,
C23-H26-N2-O2.Cl-H,
CID154058,
CID 154058,
2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-1-phenyl-,1-azabicyclo(2.2.2)oct-3-yl ester, monohydrochloride, (R-(R*,S*))-,
242478-38-2,